Schroder Investment Management Group lowered its stake in shares of Dolby Laboratories, Inc. (NYSE:DLB - Free Report) by 6.3% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 1,103,697 shares of the electronics maker's stock after selling 74,257 shares during the quarter. Schroder Investment Management Group owned 1.16% of Dolby Laboratories worth $86,155,000 at the end of the most recent quarter.
Other hedge funds have also recently made changes to their positions in the company. Vanguard Group Inc. lifted its holdings in shares of Dolby Laboratories by 1.0% during the fourth quarter. Vanguard Group Inc. now owns 7,033,612 shares of the electronics maker's stock valued at $549,325,000 after purchasing an additional 68,771 shares during the last quarter. Bank of New York Mellon Corp grew its stake in shares of Dolby Laboratories by 64.2% during the 4th quarter. Bank of New York Mellon Corp now owns 4,826,477 shares of the electronics maker's stock valued at $376,948,000 after acquiring an additional 1,887,518 shares during the period. State Street Corp increased its stake in Dolby Laboratories by 1.5% in the 3rd quarter. State Street Corp now owns 1,931,586 shares of the electronics maker's stock worth $147,824,000 after buying an additional 29,289 shares in the last quarter. Geode Capital Management LLC lifted its holdings in shares of Dolby Laboratories by 4.3% in the third quarter. Geode Capital Management LLC now owns 1,538,583 shares of the electronics maker's stock worth $117,767,000 after buying an additional 63,293 shares in the last quarter. Finally, Disciplined Growth Investors Inc. MN increased its stake in Dolby Laboratories by 4.5% in the 3rd quarter. Disciplined Growth Investors Inc. MN now owns 1,466,212 shares of the electronics maker's stock worth $112,209,000 after acquiring an additional 63,589 shares during the last quarter. 58.56% of the stock is currently owned by institutional investors.
Insider Buying and Selling at Dolby Laboratories
In related news, CAO Ryan Nicholson sold 7,000 shares of the business's stock in a transaction dated Wednesday, February 5th. The stock was sold at an average price of $84.07, for a total value of $588,490.00. Following the completion of the sale, the chief accounting officer now directly owns 29,758 shares of the company's stock, valued at $2,501,755.06. The trade was a 19.04 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, EVP Mark Andrew Sherman sold 40,000 shares of the stock in a transaction on Thursday, January 30th. The stock was sold at an average price of $84.88, for a total value of $3,395,200.00. Following the completion of the transaction, the executive vice president now directly owns 62,397 shares of the company's stock, valued at approximately $5,296,257.36. The trade was a 39.06 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 65,121 shares of company stock worth $5,501,324 over the last 90 days. Corporate insiders own 38.39% of the company's stock.
Dolby Laboratories Trading Down 6.6 %
NYSE:DLB traded down $5.10 during trading hours on Friday, hitting $72.54. The company had a trading volume of 706,219 shares, compared to its average volume of 445,458. Dolby Laboratories, Inc. has a 1 year low of $66.35 and a 1 year high of $89.66. The company has a market cap of $6.92 billion, a P/E ratio of 26.67 and a beta of 1.01. The company has a 50-day moving average of $82.03 and a 200 day moving average of $78.47.
Dolby Laboratories Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Wednesday, February 19th. Shareholders of record on Tuesday, February 11th were issued a dividend of $0.33 per share. This represents a $1.32 dividend on an annualized basis and a yield of 1.82%. The ex-dividend date was Tuesday, February 11th. Dolby Laboratories's dividend payout ratio (DPR) is 48.53%.
Analyst Ratings Changes
A number of equities analysts recently issued reports on the company. StockNews.com cut Dolby Laboratories from a "strong-buy" rating to a "buy" rating in a report on Friday, January 31st. Rosenblatt Securities reaffirmed a "buy" rating and issued a $100.00 price target on shares of Dolby Laboratories in a report on Thursday, January 30th. Finally, Barrington Research reiterated an "outperform" rating and set a $100.00 price objective on shares of Dolby Laboratories in a research note on Thursday, February 13th.
Read Our Latest Analysis on Dolby Laboratories
About Dolby Laboratories
(
Free Report)
Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.
See Also

Before you consider Dolby Laboratories, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Dolby Laboratories wasn't on the list.
While Dolby Laboratories currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report